Recombinant A2-specific TNF.alpha.-specific antibodies
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Oct 2, 2007
Grant Date -
Jun 29, 2006
app pub date -
Dec 20, 2005
filing date -
Mar 18, 1991
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Anti-TNF antibodies, fragments and regions thereof which are specific for human tumor necrosis factor-.alpha. (TNF.alpha.) and are useful in vivo diagnosis and therapy of a number of TNF.alpha.-mediated pathologies and conditions, as well as polynucleotides coding for murine and chimeric antibodies, methods of producing the antibody, methods of use of the anti-TNF antibody, or fragment, region or derivative thereof, in immunoassays and immunotherapeutic approaches are provided.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully